NCT05686369View on ClinicalTrials.gov

A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study)

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

March 8, 2023

Primary Completion Date

October 5, 2023

Study Completion Date

October 5, 2023

Conditions
Celiac Disease
Trial Locations (1)

90230

Science 37, Culver City

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY

NCT05686369 - A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study) | Biotech Hunter | Biotech Hunter